Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.scr.2017.11.003

PubMed Identifier: 29172153

Publication URI: http://europepmc.org/abstract/MED/29172153

Type: Journal Article/Review

Volume: 25

Parent Publication: Stem cell research

ISSN: 1873-5061